At present, folic acid receptors (FARs), sigma receptors, transferrin receptors (TfRs), EGFR, urokinase plasminogen activator receptors (uPARs), etc., which are overexpressed on the surface of lung cancer cells, have been applied in targeted drug delivery for lung cancer [56]. This evidence concerns the gene TFRC and lung cancer.